Wells Fargo & Co. Starts Stock Coverage on Medidata Solutions (MDSO)

By admin | 6 years ago

Equities research analysts at Wells Fargo & Co. (NYSE: WFC) started coverage on shares of Medidata Solutions (NASDAQ: MDSO) in a research note issued to investors on Wednesday. The firm set an “outperform” rating on the stock.

Several other analysts have also recently commented on the stock. Analysts at Needham & Company reiterated a “buy” rating on shares of Medidata Solutions in a research note to investors on Wednesday, May 2nd. Separately, analysts at Jefferies Group (NYSE: JEF) raised their price target on shares of Medidata Solutions from $31.00 to $34.00 in a research note to investors on Wednesday, May 2nd. Finally, analysts at Raymond James (NYSE: RJF) upgraded shares of Medidata Solutions from a “market perform” rating to an “outperform” rating in a research note to investors on Friday, April 20th.

Medidata Solutions traded up 0.79% on Wednesday, hitting $27.98. Medidata Solutions has a 1-year low of $14.07 and a 1-year high of $27.96. The company has a market cap of $678.5 million and a price-to-earnings ratio of 17.14.

Medidata Solutions last released its earnings data on Tuesday, May 1st. The company reported $0.26 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.22 by $0.04. Medidata Solutions’s revenue was up 23.5% compared to the same quarter last year. Analysts expect that Medidata Solutions will post $0.31 EPS next quarter.

Medidata Solutions, Inc. (Medidata) is a provider of hosted clinical development solutions. The Company’s customers include pharmaceutical, biotechnology and medical device companies, academic institutions, contract research organizations (CROs), and other organizations engaged in clinical trials.

About the author